expert reaction to preprints giving data on mass testing at the University of Cambridge, including transmission, genomic surveillance and participation

expert reaction to preprints giving data on mass testing at the University of Cambridge, including transmission, genomic surveillance and participation

SEMrush

Two preprints, unpublished non-peer reviewed studies, provide data on transmission, genomic surveillance and participation in Cambridge’s Asymptomatic Screening Programme.

 

Prof James Naismith, Director of the Rosalind Franklin Institute, and University of Oxford, said:

 

“Although not peer reviewed, the Cambridge experience fits with other studies and our understanding.  Mass screening by testing is an effective anti covid19 strategy; it’s not a magic bullet but it makes an important difference.  The governments in the UK have made simple to use test kits freely available.  I use them, my place of works uses them and I would urge as many people as possible to use them.  The more of us who volunteer to take part in regular screening the more effectively we will control the virus.”

 

https://www.researchsquare.com/article/rs-520627/v1

https://www.researchsquare.com/article/rs-520626/v1

https://www.cam.ac.uk/stories/safetyscreens

 

 

All our previous output on this subject can be seen at this weblink:

www.sciencemediacentre.org/tag/covid-19

 

 

Declared interests

None received.

[automaticbacklinks]